Today's Most Popular
Lapatinib May Work Against Certain Inflammatory Breast Cancers
Women with HER2+ inflammatory breast cancer who haven't responded to
other cancer treatments may benefit from lapatinib (Tykerb), according to a recent study.
More Stories in American Cancer Society News
- FDA Announces New Rules to Curb Youth Smoking
- ACS Researchers: Progress, Challenges in the War on Cancer
- Revised Prostate Cancer Screening Guidelines: What Has--and Hasn't--Changed
- Can Aspirin Reduce the Risk of Breast Cancer Recurrence?
- Prostate Cancer Hormone Therapy May Increase Heart Risk
Other Feedables
- Naperville Feeds - fresh off the vine, Naperville news
Barack Obama - hungry for change?- Photoshop News and Tutorials - It looks good enough to eat
Famous Feedables - A juicy morsel of dish.
Howard Stern Feeds - The Nobu of News.- more Feedables...